John Wityak
CHDI Foundation · 71 works · 4,502 citations · h-index 33
Top works
- Discovery of N -(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays
- Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck
- MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
- 2-Aminothiazole as a Novel Kinase Inhibitor Template. Structure−Activity Relationship Studies toward the Discovery of N -(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (Dasatinib, BMS-354825) as a Potent pan -Src Kinase Inhibitor
- Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors
- Synthesis of 1,3-Diynes Using Palladium-Copper Catalysis
- Molecular design, synthesis, and structure–Activity relationships leading to the potent and selective p56lck inhibitor BMS-243117
- Discovery of Potent Isoxazoline Glycoprotein IIb/IIIa Receptor Antagonists
- Isoxazolines as Potent Antagonists of the Integrin αvβ3
- Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa Antagonists
- Synthesis of Thrombin Inhibitor DuP 714
- A 1,3-dipolar cycloaddition route to the 3(R)- and 3(S)-hydroxy-2(S)-arginines
- Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation
- The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase
- Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56Lck
- Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors
- Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754
- Bisbenzamidine isoxazoline derivatives as factor Xa inhibitors
- Orally Active Isoxazoline GPIIb/IIIa Antagonists
- Imidazoquinoxaline Src-Family Kinase p56Lck Inhibitors: SAR, QSAR, and the Discovery of (S)-N-(2-Chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity